[HTML][HTML] Novel biomarkers for cardiovascular risk prediction
J Wang, GJ Tan, LN Han, YY Bai, M He… - Journal of geriatric …, 2017 - ncbi.nlm.nih.gov
Cardiovascular disease (CVD) is the leading cause of death and disability worldwide. The
primary prevention of CVD is dependent upon the ability to identify high-risk individuals long …
primary prevention of CVD is dependent upon the ability to identify high-risk individuals long …
[HTML][HTML] Biomarkers in pneumonia—beyond procalcitonin
M Karakioulaki, D Stolz - International journal of molecular sciences, 2019 - mdpi.com
Pneumonia is the leading infectious cause of mortality worldwide and one of the most
common lower respiratory tract infections that is contributing significantly to the burden of …
common lower respiratory tract infections that is contributing significantly to the burden of …
[PDF][PDF] Systemic inflammation in decompensated cirrhosis: characterization and role in acute‐on‐chronic liver failure
J Clària, RE Stauber, MJ Coenraad, R Moreau… - …, 2016 - Wiley Online Library
Acute‐on‐chronic liver failure (ACLF) in cirrhosis is characterized by acute decompensation
(AD), organ failure (s), and high short‐term mortality. Recently, we have proposed (systemic …
(AD), organ failure (s), and high short‐term mortality. Recently, we have proposed (systemic …
Liver transplantation for “very early” intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment
G Sapisochin, M Facciuto, L Rubbia‐Brandt, J Marti… - Hepatology, 2016 - journals.lww.com
The presence of an intrahepatic cholangiocarcinoma (iCCA) in a cirrhotic liver is a
contraindication for liver transplantation in most centers worldwide. Recent investigations …
contraindication for liver transplantation in most centers worldwide. Recent investigations …
Adverse cardiac remodelling after acute myocardial infarction: old and new biomarkers
AE Berezin, AA Berezin - Disease Markers, 2020 - Wiley Online Library
The prevalence of heart failure (HF) due to cardiac remodelling after acute myocardial
infarction (AMI) does not decrease regardless of implementation of new technologies …
infarction (AMI) does not decrease regardless of implementation of new technologies …
Fluid balance and hydration considerations for women: review and future directions
Although it is well understood that dehydration can have a major impact on exercise
performance and thermoregulatory physiology, the potential for interactions between female …
performance and thermoregulatory physiology, the potential for interactions between female …
[HTML][HTML] Electrolyte disorders induced by antineoplastic drugs
I Verzicco, G Regolisti, F Quaini, P Bocchi… - Frontiers in …, 2020 - frontiersin.org
The use of antineoplastic drugs has a central role in treatment of patients affected by cancer
but is often associated with numerous electrolyte derangements which, in many cases, could …
but is often associated with numerous electrolyte derangements which, in many cases, could …
[HTML][HTML] Aptamers targeting cardiac biomarkers as an analytical tool for the diagnostics of cardiovascular diseases: A review
N Komarova, O Panova, A Titov, A Kuznetsov - Biomedicines, 2022 - mdpi.com
The detection of cardiac biomarkers is used for diagnostics, prognostics, and the risk
assessment of cardiovascular diseases. The analysis of cardiac biomarkers is routinely …
assessment of cardiovascular diseases. The analysis of cardiac biomarkers is routinely …
Arginine vasopressin (AVP): a review of its historical perspectives, current research and multifunctional role in the hypothalamo-hypophysial system
F Rotondo, H Butz, LV Syro, GM Yousef, A Di Ieva… - Pituitary, 2016 - Springer
Introduction This publication reviews the function of arginine vasopressin and focuses on the
morphologic and functional correlation between the hormone and its effect on stress, the …
morphologic and functional correlation between the hormone and its effect on stress, the …
[HTML][HTML] Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease
RT Gansevoort, MDA van Gastel, AB Chapman… - Kidney international, 2019 - Elsevier
In the TEMPO 3: 4 Trial, treatment with tolvaptan, a vasopressin V2 receptor antagonist,
slowed the increase in total kidney volume and decline in estimated glomerular filtration rate …
slowed the increase in total kidney volume and decline in estimated glomerular filtration rate …